Navigation Links
Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Senator Tom Daschle for HHS Secretary, White House Health Reform Czar
Date:12/11/2008

omise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.

The Susan G. Komen for the Cure Advocacy Alliance is a sister organization to Susan G. Komen for the Cure(R), and is a voice for change on Capitol Hill, in state legislatures and on the campaign trail. With the help of nearly 200,000 Komen Champions and Komen's network of 122 domestic affiliates, we are aggressively seeking increased funding for research and greater access to screening and treatment. The Komen Advocacy Alliance engages policymakers and leaders at all levels of government to advocate for an increased investment in breast cancer research and greater access to breast health services.


'/>"/>
SOURCE Susan G. Komen for the Cure Advocacy Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Susan G. Komen for the Cure(R) Announces Recipients of 2008 Komen Brinker Award for Scientific Distinction
2. ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research
3. Susan Lark, MD Speaks Out Against the Newest Osteoporosis Drug, Reclast
4. The Honorable Edward M. Kennedy, Scientists Mina J. Bissell and Susan Band Horwitz, and Philanthropist Jon M. Huntsman to Receive American Cancer Society Highest Honor for Outstanding Contributions to Cancer Fight
5. Susan G. Komen for the Cure(R) Hosts Inaugural Illinois State Summit in Springfield
6. Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention
7. Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance
8. Rib-X CEO Susan Froshauer, PhD, Honored by The Connecticut Womens Hall of Fame
9. Susan Lark, MD Says "Volunteer" Your Way to Good Health this Holiday Season
10. Susan G. Komen Breast Cancer Foundation awards grant for imaging-agent research
11. Susan Lark, MD Offers 5 Tips for Managing Stress During Tough Economic Times
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:General Mills to Cut Sugar in Kids' Cereals 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 2Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 4Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 5Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 2Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 3Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 4Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 5
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 53181 1Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 53181 2ARDS Promotes Awareness with New Campaign 53177 1ARDS Promotes Awareness with New Campaign 53177 2Immune responses to flu vaccine are diminished in lupus patients 53173 1Immune responses to flu vaccine are diminished in lupus patients 53173 2